Home › Research › Clinical safety
Sublingual Crushed Levodopa for Parkinson’s Disease Management of a Lewy Body Dementia Patient With Dysphagia: A Case Report
Kristin Regehr, Jessica Yu, Fiona Wu, Reema Shah, Anthony Lau. Cureus, 2025-05-29
Topic: Brain proteins, microglia and lab models
Plain-language summary
Levodopa/carbidopa is the cornerstone treatment for Parkinson's disease (PD), but in patients with dysphagia, there are limited options for the routes of administration. Traditional methods of administering levodopa/carbidopa in these patients, such as rectal administration, have been shown to offer limited symptomatic relief and suboptimal pharmacokinetic outcomes. This case explores sublingual administration of levodopa/carbidopa as a novel solution for managing parkinsonian symptoms in dysphagic patients in the hospital setting, where non-oral options are often limited. We present an 85-year-old Caucasian male with Lewy body dementia and parkinsonian symptoms, who presented to the emergency department with dysphagia and altered level of consciousness in the context of a urinary tract infection. Due to a missed dose of levodopa/carbidopa, he exhibited worsening bradykinesia, rigidity, resting tremors, and dysphagia. Levodopa/carbidopa was crushed and administered sublingually. Symptom improvement and resolution were observed within two hours of the sublingual dose, and the patient was able to tolerate oral medications thereafter. This case demonstrates that sublingual administration of levodopa/carbidopa may be a practical and effective alternative approach for managing parkinsonian symptoms in patients with dysphagia.
What this study adds
Evidence grade: Low
In one patient with Lewy body dementia and swallowing difficulty, crushed levodopa/carbidopa given under the tongue improved parkinsonian symptoms within two hours. This is a single case report about giving an existing Parkinson's drug by a different route, not a treatment or cure for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Regehr, K., Yu, J., Wu, F., Shah, R., & Lau, A. (2025). Sublingual Crushed Levodopa for Parkinson’s Disease Management of a Lewy Body Dementia Patient With Dysphagia: A Case Report. Cureus. https://doi.org/10.7759/cureus.85064
Vancouver
Regehr K, Yu J, Wu F, Shah R, Lau A. Sublingual Crushed Levodopa for Parkinson’s Disease Management of a Lewy Body Dementia Patient With Dysphagia: A Case Report. Cureus. 2025. doi:10.7759/cureus.85064. PMID: 40585751.
BibTeX
@article{regehr2025-40585751,
author = {Regehr, Kristin and Yu, Jessica and Wu, Fiona and Shah, Reema and Lau, Anthony},
title = {{Sublingual Crushed Levodopa for Parkinson’s Disease Management of a Lewy Body Dementia Patient With Dysphagia: A Case Report}},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.85064},
pmid = {40585751},
url = {https://doi.org/10.7759/cureus.85064}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We present an 85-year-old Caucasian male with Lewy body dementia and parkinsonian symptoms, who presented to the emergency department with dysphagia and altered level of consciousness in the context of a urinary tract infection.
- Due to a missed dose of levodopa/carbidopa, he exhibited worsening bradykinesia, rigidity, resting tremors, and dysphagia.
- Levodopa/carbidopa was crushed and administered sublingually.
- Symptom improvement and resolution were observed within two hours of the sublingual dose, and the patient was able to tolerate oral medications thereafter.
- This case demonstrates that sublingual administration of levodopa/carbidopa may be a practical and effective alternative approach for managing parkinsonian symptoms in patients with dysphagia.
Why it matters
In one patient with Lewy body dementia and swallowing difficulty, crushed levodopa/carbidopa given under the tongue improved parkinsonian symptoms within two hours. This is a single case report about giving an existing Parkinson's drug by a different route, not a treatment or cure for Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Cureus) |
| Journal's citation record | 1 / 4 | Cureus: journal h-index 131 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Anthony Lau: h-index 10 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Vancouver General Hospital: institution h-index 364 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40585751) |
| Free to read | 2 / 2 | Free to read |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Clinical safety from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.